Abstract
Counselling a patient and family members about choroidal melanoma is an essential arm of management. The diagnosis, survey for metastatic disease, staging, evidence-based treatment options, local with systemic outcomes and subsequent follow up visits need to be discussed. This chapter outlines the diagnosis, choice of treatment, special considerations, recommended systemic surveys and role of genetic counselling.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1. Arch Ophthalmol. 1990;108:1268–73.
Augsburger JJ, Shields JA. Fine needle aspiration biopsy of solid intraocular tumors: indications, instrumentation and techniques. Ophthalmic Surg. 1984;15:34–40.
Caines R, Eleuteri A, Kalirai H, et al. Cluster analysis of multiplex ligation-dependent probe amplification data in choroidal melanoma. Mol Vis. 2015;21:1–11.
Finger PT, Tena LB, Semenova E, et al. Extrascleral extension of choroidal melanoma: post-enucleation high-dose-rate interstitial brachytherapy of the orbit. Brachytherapy. 2014;13:275–80.
Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report no. 28. Arch Ophthalmol. 2006;124:1684–93.
Kujala E, Damato B, Coupland SE, et al. Staging of ciliary body and choroidal melanomas based on anatomic extent. J Clin Oncol. 2013;31:2825–31.
Diener-West M, Reynolds SM, Agugliaro DJ, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol. 2005;123:1639–43.
Semenova E, Finger PT. Palladium-103 radiation therapy for small choroidal melanoma. Ophthalmology. 2013;120(11):2353–7.
Wilson MW, Hungerford JL. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology. 1999;106:1579–87.
Packer S, Stoller S, Lesser ML, et al. Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology. 1992;99:767–73.
Fontanesi J, Meyer D, Xu S, Tai D. Treatment of choroidal melanoma with I-125 plaque. Int J Radiat Oncol Biol Phys. 1993;26:619–23.
Lommatzsch PK. Beta-irradiation of choroidal melanoma with 106Ru/106Rh applicators: 16 years’ experience. Arch Ophthalmol. 1983;101:713–7.
Char DH, Kroll SM, Castro J. Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol. 1998;125:81–9.
Brovkina AF, Zarubei GD. Ciliochoroidal melanomas treated with a narrow medical proton beam. Arch Ophthalmol. 1986;104:402–4.
Gragoudas ES, Seddon JM, Egan K, et al. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology. 1987;94:349–53.
Fastenberg DM, Finger PT, Chess Q, Koizumi JH, Packer S. Vitrectomy retinotomy aspiration biopsy of choroidal tumors. Am J Ophthalmol. 1990;110:361–5.
Damato BE, Heimann H, Kalirai H, Coupland SE. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival. JAMA Ophthalmol. 2014;132(5):605–13.
Finger PT. Finger’s “slotted” eye plaque for radiation therapy: treatment of juxtapapillary and circumpapillary intraocular tumors. Br J Ophthalmol. 2007;91:891–4.
Finn AP, Materin MA, Mruthyunjaya P. Choroidal tumor biopsy: A review of the current state and a glance into future techniques. Retina. 2017;38:S79–87.
Krema H, Somani S, Sahgal A, et al. Stereotactic radiotherapy in the treatment of juxtapapillary choroidal melanoma: 3-year follow-up. Br J Ophthalmol. 2009;93:1172–6.
Sagoo MS, Shields CL, Emrich J, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma: tumor control in 650 consecutive cases. JAMA Ophthalmol. 2011;118:402–7.
Lane AM, Kin IK, Gragoudas ES. Proton irradiation for peripapillary and parapapillary melanomas. Arch Ophthalmol. 2011;129:1127–30.
The American Brachytherapy Society - Ophthalmic Oncology Task Force. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma. Brachytherapy. 2014;13:1–14.
Freton A, Chin KJ, Raut R, Tena LB, Kivelä T, Finger PT. Initial PET/CT staging for choroidal melanoma: AJCC correlation and second nonocular primaries in 333 patients. Eur J Ophthalmol. 2012;22(2):236–43.
Finger PT. Intraocular melanoma. In: DeVita Jr VT, Lawrence TS, Rosenberg SA, editors. Cancer: principles and practice of oncology. 10th ed. Philadelphia: Wolters Kluwer, Lippincott, Williams and Wilkins; 2014. p. 1770–9.
Eskelin S, Summanen P, Pyrhönen S, Tarkkanen A, Kivelä T. Screening for metastatic uveal melanoma revisited. Cancer. 1999;85:1151–9.
Kivelä T, Simpson ER, Grossniklaus HE, et al. Chapter 67: Uveal melanoma. In: Amin MB, Edge S, Greene F, editors. The AJCC cancer staging manual. 8th ed. New York: Springer; 2017. p. 805–17.
Gomez D, Wetherill C, Cheong J, et al. The Liverpool uveal melanoma liver metastases pathway: outcome following liver resection. J Surg Oncol. 2014;109(6):542–7.
Hawkins BS. Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24. Am J Ophthalmol. 2004;138:936–51.
Bergman L, Seregard S, Nilsson B, Lundell G, Ringborg U, Ragnarsson-Olding B. Uveal melanoma survival in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci. 2003;44(8):3282–7.
Kaiserman I, Amer R, Pe’er J. Liver function tests in metastatic uveal melanoma. Am J Ophthalmol. 2004;137(2):236–43.
Shields CL, Kaliki S, Furuta M, et al. American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients. Ophthalmology. 2013;120:2066–71.
Finger PT, Chin KJ, Duvall G, et al. Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients. Ophthalmology. 2009;116:790–796, 796.e1.
Saakyan SV, Panteleeva OG, Shirina TV. Metastatic disease characteristics and survival of patients with uveal melanoma depending on the method of treatment of the primary tumor. Russ Ophthalmol J. 2012;5(2):55–7.
Jampol LM, Moy CS, Murray TG, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology. 2002;109:2197–206.
Singh AD, Medina CA, Singh N, et al. Fine-needle aspiration biopsy of uveal melanoma: outcomes and complications. Br J Ophthalmol. 2016;100:456–62.
Triozzi PL, Singh AD. Adjuvant therapy of uveal melanoma: current status. Ocul Oncol Pathol. 2015;1:54–62.
Cassoux N, Rodrigues MJ, Plancher C, et al. Genome-wide profiling is a clinically relevant and affordable prognostic test in uveal melanoma posterior uveal melanoma. Br J Ophthalmol. 2014;98(6):769–74.
Ewens KG, Kanetsky PA, Richards-Yutz J, et al. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma. Invest Ophthalmol Vis Sci. 2014;55(8):5160–7.
van Beek JG, Koopmans AE, Vaarwater J, et al. The prognostic value of extraocular extension in relation to monosomy 3 and gain of chromosome 8q in uveal melanoma. Invest Ophthalmol Vis Sci. 2014;55(3):1284–91.
Mäkitie T, Summanen P, Tarkkanen A, Kivelä T. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J Natl Cancer Inst. 1999;91(4):359–67.
Shields CL, Ganguly A, Bianciotto CG, Turaka K, Tavallali A, Shields JA. Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens. Ophthalmology. 2011;118(2):396–401.
Onken MD, Worley LA, Char DH, et al. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology. 2012;119(8):1596–603.
Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 2004;64(20):7205–9.
Damato B, Dopierala JA, Coupland SE. Genotypic profiling of choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res. 2010;16(24):6083–92.
Chen X, Maniotis AJ, Majumdar D, Pe’er J, Folberg R. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Invest Ophthalmol Vis Sci. 2002;43(8):2533–9.
Mäkitie T, Summanen P, Tarkkanen A, Kivelä T. Tumorinfiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2001;42(7):1414–21.
Bronkhorst IH, Ly LV, Jordanova ES, et al. Detection of M2-macrophages in uveal melanoma and relation with survival. Invest Ophthalmol Vis Sci. 2011;52(2):643–50.
Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol. 1997;42:215–32.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Chaugule, S.S., Finger, P.T. (2020). Counseling for Patients with Choroidal Melanoma. In: Khetan, V. (eds) Intraocular Tumors. Springer, Singapore. https://doi.org/10.1007/978-981-15-0395-5_21
Download citation
DOI: https://doi.org/10.1007/978-981-15-0395-5_21
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-0394-8
Online ISBN: 978-981-15-0395-5
eBook Packages: MedicineMedicine (R0)